Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.

Suppr

超能文献

作者信息

Brown D, Scott D H, Scott D B, Meyer M, Westerlund D, Lundström J

出版信息

Eur J Clin Pharmacol. 1980 Feb;17(2):111-6. doi: 10.1007/BF00562618.

DOI:10.1007/BF00562618

PMID:6445274

Abstract

摘要

相似文献

Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.

Eur J Clin Pharmacol. 1980 Feb;17(2):111-6. doi: 10.1007/BF00562618.

Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.齐美利定在人体中的药代动力学——静脉注射和口服齐美利定后齐美利定及去甲齐美利定的血药浓度和尿排泄情况

Eur J Clin Pharmacol. 1981;20(2):135-9. doi: 10.1007/BF00607150.

Single dose pharmacokinetic data on zimelidine in depressed patients.抑郁症患者中齐美利定的单剂量药代动力学数据。

Neuropharmacology. 1980 Dec;19(12):1221-2. doi: 10.1016/0028-3908(80)90210-5.

Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.

Arzneimittelforschung. 1981;31(3):486-94.

Zimelidine and norzimelidine protein binding measured by equilibrium dialysis and cerebrospinal fluid.通过平衡透析法和脑脊液测量齐美利定和去甲齐美利定的蛋白结合率。

Clin Pharmacol Ther. 1982 Apr;31(4):522-7. doi: 10.1038/clpt.1982.70.

Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.齐美利定和去甲齐美利定与阿米替林相比的抗抑郁作用概况。

Adv Biochem Psychopharmacol. 1982;32:35-42.

[Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy].

Lakartidningen. 1983 Jan 5;80(1-2):31-2.

Zimelidine: comparison of different dosage regimes in general practice.

Acta Psychiatr Scand Suppl. 1981;290:464-70. doi: 10.1111/j.1600-0447.1981.tb00753.x.

Zimelidine: a new antidepressive.

Drug Ther Bull. 1982 Nov 26;20(24):95-6.

Severe headache and disturbed liver function during treatment with zimelidine.

Br Med J (Clin Res Ed). 1982 Oct 9;285(6347):1009. doi: 10.1136/bmj.285.6347.1009.

引用本文的文献

Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.

Psychopharmacology (Berl). 1980 Jan;67(1):1-7. doi: 10.1007/BF00427588.

Eur J Clin Pharmacol. 1981;20(2):135-9. doi: 10.1007/BF00607150.

Pharmacokinetic study of zimelidine using a new GLC method.

Clin Pharmacokinet. 1983 Nov-Dec;8(6):530-40. doi: 10.2165/00003088-198308060-00004.

Possible hepatotoxicity of zimelidine.

Br Med J (Clin Res Ed). 1983 Oct 22;287(6400):1181. doi: 10.1136/bmj.287.6400.1181.

Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.齐美利定：对其药理特性及在抑郁症治疗中的疗效综述

Drugs. 1982 Sep;24(3):169-206. doi: 10.2165/00003495-198224030-00001.

Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.大鼠反复给药后齐美利定对5-羟色胺能和去甲肾上腺素能神经元的影响。

Psychopharmacology (Berl). 1981;72(3):219-25. doi: 10.1007/BF00431820.

Influence of renal failure on the kinetics of zimeldine and norzimelidine.

Eur J Clin Pharmacol. 1985;28(4):453-6. doi: 10.1007/BF00544366.

本文引用的文献

THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN.人体肝血流量的估计

J Clin Invest. 1945 Nov;24(6):890-7. doi: 10.1172/JCI101676.

Biochemical effects of zimelidine in man.齐美利定对人体的生化作用。

Eur J Clin Pharmacol. 1980 Nov;18(6):483-7. doi: 10.1007/BF00874660.

Influence of first-pass effect on availability of drugs on oral administration.首过效应对口服给药时药物可利用度的影响。

J Pharm Sci. 1971 Sep;60(9):1338-40. doi: 10.1002/jps.2600600909.

Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.三环类抗抑郁药。II. 口服给药对大鼠中脑-下丘脑区域切片中3-H-去甲肾上腺素和14-C-5-羟色胺摄取的影响。

Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):395-408. doi: 10.1111/j.1600-0773.1975.tb00807.x.

Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.三环类抗抑郁药。I. 大鼠脑下丘脑-中脑区域切片和粗制突触体制剂中3-H-去甲肾上腺素和14-C-5-羟色胺摄取抑制作用的比较。

Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):382-94. doi: 10.1111/j.1600-0773.1975.tb00806.x.

(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.（Z）-二甲基氨基-1-（4-溴苯基）-1-（3-吡啶基）丙烯（h 102/09），一种新型的神经元5-羟色胺摄取选择性抑制剂。

Acta Pharmacol Toxicol (Copenh). 1976 Aug;39(2):152-66. doi: 10.1111/j.1600-0773.1976.tb03166.x.

Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.（Z）-和（E）-3-（4-溴苯基）-N，N-二甲基-3-（3-吡啶基）烯丙胺及其二级类似物对大鼠脑内5-羟色胺和去甲肾上腺素神经元摄取的抑制作用

Neuropharmacology. 1977 Jan;16(1):57-63. doi: 10.1016/0028-3908(77)90048-x.

Zimelidine: a therapeutic and pharmacokinetic study in depression.

Psychopharmacology (Berl). 1979 Jun 21;63(3):199-202. doi: 10.1007/BF00433549.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验